Active peptidic mimics of the second intracellular loop of the V(1A) vasopressin receptor are structurally related to the second intracellular rhodopsin loop: a combined 1H NMR and biochemical study.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Biochemistry

• Publication date

  2003-07-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI027358NPMID 12846569
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel approach to the design of synthetic radioiodinated linear V1A receptor antagonists of vasopressin.

  2009cited by this paper
• NMR structure of the second intracellular loop of the alpha 2A adrenergic receptor: evidence for a novel cytoplasmic helix.

  2002cited by this paper
• Micelle-induced curvature in a water-insoluble HIV-1 Env peptide revealed by NMR dipolar coupling measurement in stretched polyacrylamide gel.

  2002cited by this paper
• Structure of the third intracellular loop of the human cannabinoid 1 receptor.

  2002cited by this paper
• Hsc70-interacting HPD loop of the J domain of polyomavirus T antigens fluctuates in ps to ns and micros to ms.

  2002cited by this paper
• NMR solution structure and dynamics of motilin in isotropic phospholipid bicellar solution

  2002cited by this paper
• Single Amino Acid Substitutions and Deletions That Alter the G Protein Coupling Properties of the V2 Vasopressin Receptor Identified in Yeast by Receptor Random Mutagenesis*

  2001cited by this paper
• Studies on the structure of the G-protein-coupled receptor rhodopsin including the putative G-protein binding site in unactivated and activated forms.

  2001cited by this paper
• Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors.

  2001cited by this paper
• Automated assignment of ambiguous nuclear overhauser effects with ARIA.

  2001cited by this paper
• Distinct Roles of the Second and Third Cytoplasmic Loops of Bovine Rhodopsin in G Protein Activation*

  2000cited by this paper
• Crystal structure of rhodopsin: A G protein-coupled receptor.

  2000cited by this paper
• Docking of linear peptide antagonists into the human V(1a) vasopressin receptor. Identification of binding domains by photoaffinity labeling.

  1999cited by this paper
• Structure of Two Fragments of the Third Cytoplasmic Loop of the Rat Angiotensin II AT1A Receptor

  1999cited by this paper
• The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities

  1998cited by this paper
• Identification of Residues Responsible for the Selective Binding of Peptide Antagonists and Agonists in the V2 Vasopressin Receptor*

  1998cited by this paper
• Molecular Basis of V2 Vasopressin Receptor/GsCoupling Selectivity*

  1998cited by this paper
• Structure of segments of a G protein-coupled receptor: CD and NMR analysis of the Saccharomyces cerevisiae tridecapeptide pheromone receptor.

  1998cited by this paper
• The Second Intracellular Loop of the m5 Muscarinic Receptor Is the Switch Which Enables G-protein Coupling*

  1998cited by this paper
• Crystallography & NMR system: A new software suite for macromolecular structure determination.

  1998cited by this paper
• The first and second cytoplasmic loops of the G-protein receptor, rhodopsin, independently form beta-turns.

  1997cited by this paper
• Synthetic Rat V1a Vasopressin Receptor Fragments Interfere with Vasopressin Binding via Specific Interaction with the Receptor*

  1997cited by this paper
• Agonists induce conformational changes in transmembrane domains III and VI of the β2 adrenoceptor

  1997cited by this paper
• Structure and function in rhodopsin: rhodopsin mutants with a neutral amino acid at E134 have a partially activated conformation in the dark state.

  1997cited by this paper
• Three-dimensional structure of the cytoplasmic face of the G protein receptor rhodopsin.

  1997cited by this paper
• Gifa V. 4: A complete package for NMR data set processing

  1996cited by this paper
• Different Single Receptor Domains Determine the Distinct G Protein Coupling Profiles of Members of the Vasopressin Receptor Family (*)

  1996cited by this paper
• A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation*

  1996cited by this paper
• Conformational characterization of a peptide mimetic of the third cytoplasmic loop of the G‐protein coupled parathyroid hormone/parathyroid hormone related protein receptor

  1996cited by this paper
• Crankshaft motions of the polypeptide backbone in molecular dynamics simulations of human type-α transforming growth factor

  1995cited by this paper
• Identifying the mechanism of protein loop closure: a molecular dynamics simulation of the Bacillus stearothermophilus LDH loop in solution.

  1995cited by this paper
• Site of dopamine D1 receptor binding to Gs protein mapped with synthetic peptides.

  1994cited by this paper
• 5-Hydroxytryptamine1A receptor synthetic peptides. Mechanisms of adenylyl cyclase inhibition.

  1994cited by this paper
• Hydrophobic amino acid in the i2 loop plays a key role in receptor-G protein coupling.

  1993cited by this paper
• A 500 ps molecular dynamics simulation study of interleukin-1 beta in water. Correlation with nuclear magnetic resonance spectroscopy and crystallography.

  1992cited by this paper
• The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy.

  1992cited by this paper
• Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions

  1992cited by this paper
• Two peptides from the alpha 2A-adrenergic receptor alter receptor G protein coupling by distinct mechanisms.

  1991cited by this paper
• A molecular dynamics investigation of the elastomeric restoring force in elastin

  1990cited by this paper
• Three cytoplasmic loops of rhodopsin interact with transducin.

  1989cited by this paper
• Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis.

  1986cited by this paper
• Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

  1978cited by this paper

• Urotensin-II peptidomimetic incorporating a non-reducible 1,5-triazole disulfide bond reveals a pseudo-irreversible covalent binding mechanism to the urotensin G-protein coupled receptor.

  2017cites this paper
• Rational design of a peptide capture agent for CXCL8 based on a model of the CXCL8:CXCR1 complex

  2015cites this paper
• Investigation of Interactions at the Extracellular Loops of the Relaxin Family Peptide Receptor 1 (RXFP1)*

  2014influential citation
• Lifting the lid on GPCRs: the role of extracellular loops

  2011cites this paper
• GPCRs Revisited: New Insights Lead to Novel Drugs

  2011cites this paper
• Structure and function of V1b vasopressin receptor

  2010cites this paper
• GPCR Conformations: Implications for Rational Drug Design

  2010cites this paper
• Membrane protein fragments reveal both secondary and tertiary structure of membrane proteins.

  2010cites this paper
• Targeting V1A‐vasopressin receptors with [Arg6, D‐Trp7,9, NmePhe8]‐substance P (6‐11) identifies a strategy to develop novel anti‐cancer therapies

  2009cites this paper
• On-surface Cyclization of Tetrapeptides using Molecularly Imprinted Polymers as Non-covalent Auxiliaries

  2009cites this paper
• Structure of the third intracellular loop of the vasopressin V2 receptor and conformational changes upon binding to gC1qR.

  2009cites this paper
• Unraveling the structure and function of G protein-coupled receptors through NMR spectroscopy.

  2009cites this paper
• Solution NMR of signal peptidase, a membrane protein.

  2008cites this paper
• Investigation fonctionnelle et structurale des mécanismes d'activation ou de régulation de RCPGs opiacés basée sur une approche par fragments

  2008cites this paper
• Peptide design and structural characterization of a GPCR loop mimetic.

  2007cites this paper
• Studies of the molecular mechanisms of action of relaxin on the adenylyl cyclase signaling system using synthetic peptides derived from the LGR7 relaxin receptor

  2007cites this paper
• G-protein coupled receptor structure.

  2007cites this paper
• An overview of recent developments in GPCR modelling: methods and validation

  2006cites this paper
• Efficient methodology for the cyclization of linear peptide libraries via intramolecular S‐alkylation using Multipin™ solid phase peptide synthesis

  2006cites this paper
• A beta-arrestin binding determinant common to the second intracellular loops of rhodopsin family G protein-coupled receptors.

  2006cites this paper
• A β-Arrestin Binding Determinant Common to the Second Intracellular Loops of Rhodopsin Family G Protein-coupled Receptors*

  2006cites this paper
• Characterization of urotensin-II receptor structural domains involved in the recognition of U-II, URP, and urantide.

  2006cites this paper
• Solution NMR spectroscopy of the human vasopressin V2 receptor, a G protein-coupled receptor.

  2005cites this paper
• Chemical scale investigations of ligand-gated ion channels using unnatural amino acids

  2005cites this paper
• Structure—Function Relationships in G Protein-Coupled Receptors

  2005cites this paper
• Biosynthesis and NMR analysis of a 73-residue domain of a Saccharomyces cerevisiae G protein-coupled receptor.

  2005cites this paper
• Use of Peptide Strategy for Study of Molecular Mechanisms of Hormonal Signal Transduction into Cell

  2005cites this paper
• A Cyclic Peptide Mimicking the Third Intracellular Loop of the V2 Vasopressin Receptor Inhibits Signaling through Its Interaction with Receptor Dimer and G Protein*

  2004cites this paper
• Shape‐mimetics of G‐protein‐coupled receptors in therapeutic drug design and screening

  2004cites this paper